Article

An RNA biomarker panel for the diagnosis of Alzheimer’s disease from whole blood

2025-08-07

Abstract excerpt

Alzheimer’s Disease (AD) diagnosis remains primarily clinical, relying on patient history, cognitive tests, and sometimes brain imaging. Emerging approaches include advanced neuroimaging techniques and the use of protein biomarkers in cerebrospinal fluid and plasma. However, these methods have limitations such as high costs and the need for specialized infrastructures. In contrast, analysis of RNA expression in bl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5dd7df69-998d-5582-8a62-62dc4b701bf0
DOI: 10.1101/2025.08.04.25332553

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An RNA biomarker panel for the diagnosis of Alzheimer’s disease from whole bloodDOI 10.1101/2025.08.04.25332553Read

Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s DiseaseSemantic proximity Read

Blood-Based Circular RNAs Enable Early and Accurate Alzheimer’s Disease DiagnosisSemantic proximity Read

Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expressionSemantic proximity Read

Exploratory Single-Cell RNA Sequencing of Peripheral Blood Identifies Candidate Signatures Associated with Alzheimer’s DiseaseSemantic proximity Read

Blood-based transcriptomic biomarkers are predictive of neurodegeneration rather than Alzheimer’s diseaseSemantic proximity Read

Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s diseaseSemantic proximity Read

Exosomal mRNA Signatures as Predictive Biomarkers for Risk and Age of Onset in Alzheimer’s DiseaseSemantic proximity Read

Assess Alzheimer’s Disease via Plasma Extracellular Vesicle-derived mRNASemantic proximity Read

Validation of AclarusDx™, a Blood-Based Transcriptomic Signature for the Diagnosis of Alzheimer's DiseaseSemantic proximity Read

A blood based 12-miRNA signature of Alzheimer disease patientsSemantic proximity Read

Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseaseSemantic proximity Read

Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's DiseaseSemantic proximity Read